Course Description
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| Neoplasia Hemopoetic System | 12. Module | Fall Semester | 79+28 | - | 7 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Committee |
| Course Coordinator | Prof.Dr. Bahar MÜEZZİNOĞLU |
| Name of Lecturer(s) | Prof.Dr. Bahar MÜEZZİNOĞLU |
| Assistant(s) | Prof.Dr. Bahar MÜEZZİNOĞLU Dr.Öğr. Ferhat ÖZDEN Doç.Dr. Volkan Aydın Prof.Dr. Seniye Sema ANAK, Doç.Dr. Yöntem Yaman Dr.Öğr.Üyesi Mustafa ÇİFTÇİ Dr.Öğr.Üye. Hüseyin Saffet BEKÖZ, Dr.Öğr.Üye. Ömer YAZICI Dr.Öğr.Üye. Özlem GÜVEN "Prof.Dr. Mesut YILMAZ, Doç.Dr. Mehmet Sait DOĞAN, Dr.Öğr.Üye. Tansel ÇAKIR, |
| Aim | The aim of this committee is; to provide making the description of the molecular steps and pathogenesis of carcinogenesis, explanation of the pathogenesis of common diseases of the bone marrow, spleen and lymph nodes, description of their clinical features; description and discussion of the characteristic morphological appearance of neoplastic diseases, their classification, biological behavior and staging; explaining the etiopathogenesis of hematological tumors and non-tumoral common diseases, list the diagnostic procedures and description the main differential diagnostic features; explanation of the etiopathogenesis of common allergic diseases in childhood, list the diagnostic procedures and description the main differential diagnostic features; definition of the basic principles for the control of infectious diseases; the classification of viruses and the explanation of the pathogenesis of viral diseases, the grouping of viruses of clinical importance and their association with their clinical characteristics; explanation and discussion the basic principles of rational drug use; the classification of drugs used in anemia and cancer patients, the discussion of their clinical use and side effects, the classification of antimicrobial drugs, their clinical use and side effects; definition epidemiology in terms of public health and quality of life; identification of radiation, description of its clinical uses; explanation of the basic features of tumor biochemistry and group them according to diseases. |
| Course Content | This course contains; Patoloji- Neoplazi: Tanım, terminoloji, genel prensipler (1,2) ,Patoloji-Kanser epidemiyolojisi ve etiyolojisi (1,2) -,Patoloji- Tümörlerde tanı patolojisi ve prognozu,Patoloji-İyi huylu ve kötü huylu neoplazmın özellikleri,Patoloji-Kanserin moleküler temelleri (Kanserojenez) 1-2,Patoloji-BM Kanserin moleküler temeli (Karsinogenez)3-4-5,Patoloji-Kemik iliği patolojisi (1,2) ,Patoloji-Lenf Nodu patolojisi (1,2,3) ,Patoloji - Dalak ve timik hastalıkların patolojisi,Biyokimya-1-Tümör Biyokimyası,Biyokimya-2-Plazma Proteinleri ve İmmünoglobulinler,Biyokimya-3-Laboratuvar örneğinin uygun şartlarda alınması ve laboratuvara taşınması,Pediatri - Hematolojik hastalıklarda tarih, fizik muayene ve tanı yöntemleri,Pediatri - Kan Transfüzyonu,Pediatri - Çocukluk çağındaki tümörler,Pediati-Anemi,Pediatri -Alerjik hastalıklarda tarih ve fizik muayene,Enfeksiyon Hastalıkları - Ateş Patogenezi ve Ateş Çeşitleri,Enfeksiyon Hastalıkları -Transfüzyonla İlgili Enfeksiyonlar,Enfeksiyon Hastalıkları-Yetişkinlerde Özel Konakçı Enfeksiyonlarına Yaklaşım,Tıbbi Farmakoloji - Giriş ve ön test,Tıbbi Farmakoloji-Akılcı ilaç kullanımının temelleri,Tıbbi Farmakoloji-Otakoidler,Tıbbi Farmakoloji-Histamin, Serotonin ve antagonistleri Peptit kökenli Interleukins, Prostaglandins ve Nitric oxit Autacoids,Tıbbi Farmakoloji-Anemi tedavisinde kullanılan ilaçlar,Tıbbi Farmakoloji-Kanser tedavisinin farmakolojik temelleri,Tıbbi Farmakoloji-Antineoplastik Ajanlar,Tıbbi Farmakoloji-Antimikrobiyal kemoterapötiklerin temel özellikleri,Tıbbi Farmakoloji-Penisilinler, Sefalosporinler,Tıbbi Farmakoloji - Beta laktamaz inhibitörleri, monobaktamlar, karbapenemler ve vankomisin,Tıbbi Farmakoloji-Aminoglikozitler,Tıbbi Farmakoloji -Tetrasiklinler,Tıbbi Farmakoloji -Makrolidler,Tıbbi Farmakoloji -Kuinolonlar,Tıbbi Farmakoloji - Sülfonamidler ve Cotrimoksazol,Tıbbi Farmakoloji-Antianaerobik ajanlar,Tıbbi Farmakoloji-Antiviral Ajanlar,Tıbbi Farmakoloji - Antifungal Ajanlar,Tıbbi Farmakoloji-Antimalaryal Ajanlar,İç Hastalıkları- Lökosit sayılarına yaklaşım ve değişiklikler 1-2,İç Hastalıkları-Anemili Hastaya Yaklaşım 1-2,İç Hastalıkları-Lenfadenomegali ve splenomegalili hastaya yaklaşım 1-2,İç Hastalıkları-Radyasyon Onkolojisi-Radyoterapinin Kanserdeki Yeri 1-2,İç Hastalıkları-Kanama ve Pıhtılaşma Bozukluklarına Yaklaşım 1-2,İç Hastalıkları-Hematopoietik sistem muayenesi ve hematopoez,Mikrobiyoloji -Virüslere Giriş 1-2,Mikrobiyoloji-DNA Virüsleri Bulaşıcı İnsan 1-2-3-4,Mikrobiyoloji-Hepatit Virüsleri 7-8,Mikrobiyoloji - insanları enfekte eden RNA Virüsleri 1-2,Public Health -Cancer Epidemiology ,Public Health -Quality of Life-,Public Health -Genetic Epidemiology,Public Health -Vector-borne Diseases,Scientific Research-Epidemiology and Its Applications,Radiology-1-Contrast agents and, Radiation security 1-2 ,Radiology-Radiological Imaging methods1-2,Radiology-Nuclear Medicine-Radiation, Biological Effects and Radiation Accidents 1-2,Radiology-Nuclear Medicine-PET / CT in Oncology 1-2,Radiology-Nuclear Medicine-Radiation Units, Measurement,Radiology- Overview of diagnosis and treatment in nuclear medicine. |
| Course Learning Outcomes | Teaching Methods | Assessment Methods |
| Evaluate the basic subjects and laboratory techniques of pathology and obtain basic information about the functioning of the pathology laboratory. | A, B, C | |
| Makes the definition of pathology. | ||
| Defines the methods used by pathology and gives examples. | 16 | A, D |
| Will be able to evaluate the basic concepts of cellular changes, adaptation mechanisms, cell damage and inflammation against injury. | ||
| Evaluate the basic subjects and laboratory techniques of pathology and obtain basic information about the functioning of the pathology laboratory. | ||
| Defines the causes and mechanisms of cell damage, cell death and necrosis, physiopathological changes that occur as a result of cellular aging. | ||
| Learns the difference between apoptosis and necrosis, understands the mechanism of apoptosis. | ||
| Evaluate the basic concepts of neoplasia and carcinogenesis. | ||
| Nomenclature of tumours, defines the basic characteristics of malignant and benign tumours. | ||
| Understands the factors that cause cancer formation, the basics of cancer epidemiology. | ||
| Summarises the stages of cancer spread and grading and staging of tumours and gives examples. | ||
| Understands the clinical and laboratory findings of cancer. | ||
| Summarises the functioning of the immune system in normal and pathological processes. Knows the normal elements of the immune system. | ||
| Summarises the basic mechanisms of hypersensitivity reactions, various examples. | ||
| Gives information about the basics of autoimmune disorders and immunodeficiencies. | ||
| Defines the general characteristics of haematological diseases. | ||
| Recognises the normal structure of the lymph node. Defines reactive changes in the lymph node. | ||
| Classifies haematological malignancies according to cell types. | ||
| Classifies white blood cell diseases in bone marrow. | ||
| Knows the diseases with spleen involvement. |
| Teaching Methods: | 16: Question - Answer Technique |
| Assessment Methods: | A: Traditional Written Exam, B: Short Answer Exam, C: Multiple-Choice Exam, D: Oral Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Patoloji- Neoplazi: Tanım, terminoloji, genel prensipler (1,2) | |
| 2 | Patoloji-Kanser epidemiyolojisi ve etiyolojisi (1,2) - | |
| 3 | Patoloji- Tümörlerde tanı patolojisi ve prognozu | |
| 4 | Patoloji-İyi huylu ve kötü huylu neoplazmın özellikleri | |
| 5 | Patoloji-Kanserin moleküler temelleri (Kanserojenez) 1-2 | |
| 6 | Patoloji-BM Kanserin moleküler temeli (Karsinogenez)3-4-5 | |
| 7 | Patoloji-Kemik iliği patolojisi (1,2) | |
| 8 | Patoloji-Lenf Nodu patolojisi (1,2,3) | |
| 9 | Patoloji - Dalak ve timik hastalıkların patolojisi | |
| 10 | Biyokimya-1-Tümör Biyokimyası | |
| 11 | Biyokimya-2-Plazma Proteinleri ve İmmünoglobulinler | |
| 12 | Biyokimya-3-Laboratuvar örneğinin uygun şartlarda alınması ve laboratuvara taşınması | |
| 13 | Pediatri - Hematolojik hastalıklarda tarih, fizik muayene ve tanı yöntemleri | |
| 14 | Pediatri - Kan Transfüzyonu | |
| 15 | Pediatri - Çocukluk çağındaki tümörler | |
| 16 | Pediati-Anemi | |
| 17 | Pediatri -Alerjik hastalıklarda tarih ve fizik muayene | |
| 18 | Enfeksiyon Hastalıkları - Ateş Patogenezi ve Ateş Çeşitleri | |
| 18 | Enfeksiyon Hastalıkları -Transfüzyonla İlgili Enfeksiyonlar | |
| 19 | Enfeksiyon Hastalıkları-Yetişkinlerde Özel Konakçı Enfeksiyonlarına Yaklaşım | |
| 20 | Tıbbi Farmakoloji - Giriş ve ön test | |
| 21 | Tıbbi Farmakoloji-Akılcı ilaç kullanımının temelleri | |
| 22 | Tıbbi Farmakoloji-Otakoidler | |
| 23 | Tıbbi Farmakoloji-Histamin, Serotonin ve antagonistleri Peptit kökenli Interleukins, Prostaglandins ve Nitric oxit Autacoids | |
| 24 | Tıbbi Farmakoloji-Anemi tedavisinde kullanılan ilaçlar | |
| 25 | Tıbbi Farmakoloji-Kanser tedavisinin farmakolojik temelleri | |
| 26 | Tıbbi Farmakoloji-Antineoplastik Ajanlar | |
| 27 | Tıbbi Farmakoloji-Antimikrobiyal kemoterapötiklerin temel özellikleri | |
| 28 | Tıbbi Farmakoloji-Penisilinler, Sefalosporinler | |
| 29 | Tıbbi Farmakoloji - Beta laktamaz inhibitörleri, monobaktamlar, karbapenemler ve vankomisin | |
| 30 | Tıbbi Farmakoloji-Aminoglikozitler | |
| 31 | Tıbbi Farmakoloji -Tetrasiklinler | |
| 32 | Tıbbi Farmakoloji -Makrolidler | |
| 33 | Tıbbi Farmakoloji -Kuinolonlar | |
| 34 | Tıbbi Farmakoloji - Sülfonamidler ve Cotrimoksazol | |
| 35 | Tıbbi Farmakoloji-Antianaerobik ajanlar | |
| 36 | Tıbbi Farmakoloji-Antiviral Ajanlar | |
| 37 | Tıbbi Farmakoloji - Antifungal Ajanlar | |
| 38 | Tıbbi Farmakoloji-Antimalaryal Ajanlar | |
| 39 | İç Hastalıkları- Lökosit sayılarına yaklaşım ve değişiklikler 1-2 | |
| 40 | İç Hastalıkları-Anemili Hastaya Yaklaşım 1-2 | |
| 41 | İç Hastalıkları-Lenfadenomegali ve splenomegalili hastaya yaklaşım 1-2 | |
| 42 | İç Hastalıkları-Radyasyon Onkolojisi-Radyoterapinin Kanserdeki Yeri 1-2 | |
| 43 | İç Hastalıkları-Kanama ve Pıhtılaşma Bozukluklarına Yaklaşım 1-2 | |
| 44 | İç Hastalıkları-Hematopoietik sistem muayenesi ve hematopoez | |
| 45 | Mikrobiyoloji -Virüslere Giriş 1-2 | |
| 46 | Mikrobiyoloji-DNA Virüsleri Bulaşıcı İnsan 1-2-3-4 | |
| 47 | Mikrobiyoloji-Hepatit Virüsleri 7-8 | |
| 48 | Mikrobiyoloji - insanları enfekte eden RNA Virüsleri 1-2 | |
| 49 | Public Health -Cancer Epidemiology | none |
| 50 | Public Health -Quality of Life- | none |
| 51 | Public Health -Genetic Epidemiology | none |
| 52 | Public Health -Vector-borne Diseases | none |
| 53 | Scientific Research-Epidemiology and Its Applications | none |
| 54 | Radiology-1-Contrast agents and, Radiation security 1-2 | none |
| 55 | Radiology-Radiological Imaging methods1-2 | none |
| 56 | Radiology-Nuclear Medicine-Radiation, Biological Effects and Radiation Accidents 1-2 | none |
| 57 | Radiology-Nuclear Medicine-PET / CT in Oncology 1-2 | none |
| 58 | Radiology-Nuclear Medicine-Radiation Units, Measurement | none |
| 59 | Radiology- Overview of diagnosis and treatment in nuclear medicine | none |
| Resources |
| Lecture notes, Robbins/Kumar Pathologic basis of disease, macroscopic specimens, Jawetz Melnick & Adelbergs Medical Microbiology, 27th Edition, Nelson Textbook of Pediatrics, 2-Volume Set 21st Edition, Harrison's Principles of Internal Medicine, 20e |
| power point presentation, macroscopic plays, video presentation, brainstorming, case studies, question/answer |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ1: Knows the morphological and functional normal and abnormal structure of human body. | X | |||||
| 2 | PQ2: Knows the essential ways of determining the underlying causes of the pathologies with basic scientific approaches and the diagnoses of illnesses and disorders. | X | |||||
| 3 | PQ3: Knows the reasons for illnesses, the ways of protection, and the methods of promotion and improvement of public health. | ||||||
| 4 | PQ4: Knows the methods of advancing his/her knowledge about health and its practice. | ||||||
| 5 | PQ5: Accesses, interprets and applies the advanced interdisciplinary information related to health. | X | |||||
| 6 | PQ6: Performs a complete clinical examination of the human body, both morphologically and functionally and defines the problems. | X | |||||
| 7 | PQ7: Interprets examination data for diagnoses, compares with clinical data, and provides solutions. | X | |||||
| 8 | PQ8: Selects and applies appropriate tools for promotion and improvement of individual and public health. | X | |||||
| 9 | PQ9: Plans and conducts an advanced study of health independently. | ||||||
| 10 | PQ10: Takes responsibility individually and as a team member to solve the problems encountered in the promotion and improvement of individual and public health. | X | |||||
| 11 | PQ11: Takes responsibility for any intervention on the human body for the diagnosis and treatment. | X | |||||
| 12 | PQ12: Determines personal learning requirements and decides and develops a positive lifelong learning attitude. | X | |||||
| 13 | PQ13: Evaluates the information gained in the field of health with a critical approach. | X | |||||
| 14 | PQ14: Informs the patient, the relevant people and institutions, and the public about the health problem and conveys recommendations of solutions in writing and/or verbally. | X | |||||
| 15 | PQ15: Shares their recommendations on promotion and improvement of health with interdisciplinary experts by supporting with data. | X | |||||
| 16 | PQ16: Uses English at least at the General Level of European Language Portfolio B1, follows resources in his/her field and communicates. | X | |||||
| 17 | PQ17: Uses computer software, information, and communication technologies at least at the Advanced Level of European Computer Operating License. | X | |||||
| 18 | PQ18: Acts in accordance with social, scientific, cultural and ethical values in the stages of obtaining, interpreting, applying and announcing the data related to the field of health. | X | |||||
| 19 | PQ19: Develops strategy, policy and implementation plans on health issues and evaluate the results obtained the framework of quality processes. | ||||||
| 20 | PQ20: Systematically shares his/her works on promoting and improving health with quantitative and qualitative data and interdisciplinary experts. | ||||||
| 21 | PQ21: Has sufficient awareness on occupational health and safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 60 | |
| Rate of Final Exam to Success | 40 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 80 | 1 | 80 | |||
| Guided Problem Solving | 15 | 2 | 30 | |||
| Resolution of Homework Problems and Submission as a Report | 5 | 2 | 10 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 0 | 0 | 0 | |||
| General Exam | 40 | 3 | 120 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 240 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(240/30) | 8 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| Neoplasia Hemopoetic System | 12. Module | Fall Semester | 79+28 | - | 7 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Committee |
| Course Coordinator | Prof.Dr. Bahar MÜEZZİNOĞLU |
| Name of Lecturer(s) | Prof.Dr. Bahar MÜEZZİNOĞLU |
| Assistant(s) | Prof.Dr. Bahar MÜEZZİNOĞLU Dr.Öğr. Ferhat ÖZDEN Doç.Dr. Volkan Aydın Prof.Dr. Seniye Sema ANAK, Doç.Dr. Yöntem Yaman Dr.Öğr.Üyesi Mustafa ÇİFTÇİ Dr.Öğr.Üye. Hüseyin Saffet BEKÖZ, Dr.Öğr.Üye. Ömer YAZICI Dr.Öğr.Üye. Özlem GÜVEN "Prof.Dr. Mesut YILMAZ, Doç.Dr. Mehmet Sait DOĞAN, Dr.Öğr.Üye. Tansel ÇAKIR, |
| Aim | The aim of this committee is; to provide making the description of the molecular steps and pathogenesis of carcinogenesis, explanation of the pathogenesis of common diseases of the bone marrow, spleen and lymph nodes, description of their clinical features; description and discussion of the characteristic morphological appearance of neoplastic diseases, their classification, biological behavior and staging; explaining the etiopathogenesis of hematological tumors and non-tumoral common diseases, list the diagnostic procedures and description the main differential diagnostic features; explanation of the etiopathogenesis of common allergic diseases in childhood, list the diagnostic procedures and description the main differential diagnostic features; definition of the basic principles for the control of infectious diseases; the classification of viruses and the explanation of the pathogenesis of viral diseases, the grouping of viruses of clinical importance and their association with their clinical characteristics; explanation and discussion the basic principles of rational drug use; the classification of drugs used in anemia and cancer patients, the discussion of their clinical use and side effects, the classification of antimicrobial drugs, their clinical use and side effects; definition epidemiology in terms of public health and quality of life; identification of radiation, description of its clinical uses; explanation of the basic features of tumor biochemistry and group them according to diseases. |
| Course Content | This course contains; Patoloji- Neoplazi: Tanım, terminoloji, genel prensipler (1,2) ,Patoloji-Kanser epidemiyolojisi ve etiyolojisi (1,2) -,Patoloji- Tümörlerde tanı patolojisi ve prognozu,Patoloji-İyi huylu ve kötü huylu neoplazmın özellikleri,Patoloji-Kanserin moleküler temelleri (Kanserojenez) 1-2,Patoloji-BM Kanserin moleküler temeli (Karsinogenez)3-4-5,Patoloji-Kemik iliği patolojisi (1,2) ,Patoloji-Lenf Nodu patolojisi (1,2,3) ,Patoloji - Dalak ve timik hastalıkların patolojisi,Biyokimya-1-Tümör Biyokimyası,Biyokimya-2-Plazma Proteinleri ve İmmünoglobulinler,Biyokimya-3-Laboratuvar örneğinin uygun şartlarda alınması ve laboratuvara taşınması,Pediatri - Hematolojik hastalıklarda tarih, fizik muayene ve tanı yöntemleri,Pediatri - Kan Transfüzyonu,Pediatri - Çocukluk çağındaki tümörler,Pediati-Anemi,Pediatri -Alerjik hastalıklarda tarih ve fizik muayene,Enfeksiyon Hastalıkları - Ateş Patogenezi ve Ateş Çeşitleri,Enfeksiyon Hastalıkları -Transfüzyonla İlgili Enfeksiyonlar,Enfeksiyon Hastalıkları-Yetişkinlerde Özel Konakçı Enfeksiyonlarına Yaklaşım,Tıbbi Farmakoloji - Giriş ve ön test,Tıbbi Farmakoloji-Akılcı ilaç kullanımının temelleri,Tıbbi Farmakoloji-Otakoidler,Tıbbi Farmakoloji-Histamin, Serotonin ve antagonistleri Peptit kökenli Interleukins, Prostaglandins ve Nitric oxit Autacoids,Tıbbi Farmakoloji-Anemi tedavisinde kullanılan ilaçlar,Tıbbi Farmakoloji-Kanser tedavisinin farmakolojik temelleri,Tıbbi Farmakoloji-Antineoplastik Ajanlar,Tıbbi Farmakoloji-Antimikrobiyal kemoterapötiklerin temel özellikleri,Tıbbi Farmakoloji-Penisilinler, Sefalosporinler,Tıbbi Farmakoloji - Beta laktamaz inhibitörleri, monobaktamlar, karbapenemler ve vankomisin,Tıbbi Farmakoloji-Aminoglikozitler,Tıbbi Farmakoloji -Tetrasiklinler,Tıbbi Farmakoloji -Makrolidler,Tıbbi Farmakoloji -Kuinolonlar,Tıbbi Farmakoloji - Sülfonamidler ve Cotrimoksazol,Tıbbi Farmakoloji-Antianaerobik ajanlar,Tıbbi Farmakoloji-Antiviral Ajanlar,Tıbbi Farmakoloji - Antifungal Ajanlar,Tıbbi Farmakoloji-Antimalaryal Ajanlar,İç Hastalıkları- Lökosit sayılarına yaklaşım ve değişiklikler 1-2,İç Hastalıkları-Anemili Hastaya Yaklaşım 1-2,İç Hastalıkları-Lenfadenomegali ve splenomegalili hastaya yaklaşım 1-2,İç Hastalıkları-Radyasyon Onkolojisi-Radyoterapinin Kanserdeki Yeri 1-2,İç Hastalıkları-Kanama ve Pıhtılaşma Bozukluklarına Yaklaşım 1-2,İç Hastalıkları-Hematopoietik sistem muayenesi ve hematopoez,Mikrobiyoloji -Virüslere Giriş 1-2,Mikrobiyoloji-DNA Virüsleri Bulaşıcı İnsan 1-2-3-4,Mikrobiyoloji-Hepatit Virüsleri 7-8,Mikrobiyoloji - insanları enfekte eden RNA Virüsleri 1-2,Public Health -Cancer Epidemiology ,Public Health -Quality of Life-,Public Health -Genetic Epidemiology,Public Health -Vector-borne Diseases,Scientific Research-Epidemiology and Its Applications,Radiology-1-Contrast agents and, Radiation security 1-2 ,Radiology-Radiological Imaging methods1-2,Radiology-Nuclear Medicine-Radiation, Biological Effects and Radiation Accidents 1-2,Radiology-Nuclear Medicine-PET / CT in Oncology 1-2,Radiology-Nuclear Medicine-Radiation Units, Measurement,Radiology- Overview of diagnosis and treatment in nuclear medicine. |
| Course Learning Outcomes | Teaching Methods | Assessment Methods |
| Evaluate the basic subjects and laboratory techniques of pathology and obtain basic information about the functioning of the pathology laboratory. | A, B, C | |
| Makes the definition of pathology. | ||
| Defines the methods used by pathology and gives examples. | 16 | A, D |
| Will be able to evaluate the basic concepts of cellular changes, adaptation mechanisms, cell damage and inflammation against injury. | ||
| Evaluate the basic subjects and laboratory techniques of pathology and obtain basic information about the functioning of the pathology laboratory. | ||
| Defines the causes and mechanisms of cell damage, cell death and necrosis, physiopathological changes that occur as a result of cellular aging. | ||
| Learns the difference between apoptosis and necrosis, understands the mechanism of apoptosis. | ||
| Evaluate the basic concepts of neoplasia and carcinogenesis. | ||
| Nomenclature of tumours, defines the basic characteristics of malignant and benign tumours. | ||
| Understands the factors that cause cancer formation, the basics of cancer epidemiology. | ||
| Summarises the stages of cancer spread and grading and staging of tumours and gives examples. | ||
| Understands the clinical and laboratory findings of cancer. | ||
| Summarises the functioning of the immune system in normal and pathological processes. Knows the normal elements of the immune system. | ||
| Summarises the basic mechanisms of hypersensitivity reactions, various examples. | ||
| Gives information about the basics of autoimmune disorders and immunodeficiencies. | ||
| Defines the general characteristics of haematological diseases. | ||
| Recognises the normal structure of the lymph node. Defines reactive changes in the lymph node. | ||
| Classifies haematological malignancies according to cell types. | ||
| Classifies white blood cell diseases in bone marrow. | ||
| Knows the diseases with spleen involvement. |
| Teaching Methods: | 16: Question - Answer Technique |
| Assessment Methods: | A: Traditional Written Exam, B: Short Answer Exam, C: Multiple-Choice Exam, D: Oral Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Patoloji- Neoplazi: Tanım, terminoloji, genel prensipler (1,2) | |
| 2 | Patoloji-Kanser epidemiyolojisi ve etiyolojisi (1,2) - | |
| 3 | Patoloji- Tümörlerde tanı patolojisi ve prognozu | |
| 4 | Patoloji-İyi huylu ve kötü huylu neoplazmın özellikleri | |
| 5 | Patoloji-Kanserin moleküler temelleri (Kanserojenez) 1-2 | |
| 6 | Patoloji-BM Kanserin moleküler temeli (Karsinogenez)3-4-5 | |
| 7 | Patoloji-Kemik iliği patolojisi (1,2) | |
| 8 | Patoloji-Lenf Nodu patolojisi (1,2,3) | |
| 9 | Patoloji - Dalak ve timik hastalıkların patolojisi | |
| 10 | Biyokimya-1-Tümör Biyokimyası | |
| 11 | Biyokimya-2-Plazma Proteinleri ve İmmünoglobulinler | |
| 12 | Biyokimya-3-Laboratuvar örneğinin uygun şartlarda alınması ve laboratuvara taşınması | |
| 13 | Pediatri - Hematolojik hastalıklarda tarih, fizik muayene ve tanı yöntemleri | |
| 14 | Pediatri - Kan Transfüzyonu | |
| 15 | Pediatri - Çocukluk çağındaki tümörler | |
| 16 | Pediati-Anemi | |
| 17 | Pediatri -Alerjik hastalıklarda tarih ve fizik muayene | |
| 18 | Enfeksiyon Hastalıkları - Ateş Patogenezi ve Ateş Çeşitleri | |
| 18 | Enfeksiyon Hastalıkları -Transfüzyonla İlgili Enfeksiyonlar | |
| 19 | Enfeksiyon Hastalıkları-Yetişkinlerde Özel Konakçı Enfeksiyonlarına Yaklaşım | |
| 20 | Tıbbi Farmakoloji - Giriş ve ön test | |
| 21 | Tıbbi Farmakoloji-Akılcı ilaç kullanımının temelleri | |
| 22 | Tıbbi Farmakoloji-Otakoidler | |
| 23 | Tıbbi Farmakoloji-Histamin, Serotonin ve antagonistleri Peptit kökenli Interleukins, Prostaglandins ve Nitric oxit Autacoids | |
| 24 | Tıbbi Farmakoloji-Anemi tedavisinde kullanılan ilaçlar | |
| 25 | Tıbbi Farmakoloji-Kanser tedavisinin farmakolojik temelleri | |
| 26 | Tıbbi Farmakoloji-Antineoplastik Ajanlar | |
| 27 | Tıbbi Farmakoloji-Antimikrobiyal kemoterapötiklerin temel özellikleri | |
| 28 | Tıbbi Farmakoloji-Penisilinler, Sefalosporinler | |
| 29 | Tıbbi Farmakoloji - Beta laktamaz inhibitörleri, monobaktamlar, karbapenemler ve vankomisin | |
| 30 | Tıbbi Farmakoloji-Aminoglikozitler | |
| 31 | Tıbbi Farmakoloji -Tetrasiklinler | |
| 32 | Tıbbi Farmakoloji -Makrolidler | |
| 33 | Tıbbi Farmakoloji -Kuinolonlar | |
| 34 | Tıbbi Farmakoloji - Sülfonamidler ve Cotrimoksazol | |
| 35 | Tıbbi Farmakoloji-Antianaerobik ajanlar | |
| 36 | Tıbbi Farmakoloji-Antiviral Ajanlar | |
| 37 | Tıbbi Farmakoloji - Antifungal Ajanlar | |
| 38 | Tıbbi Farmakoloji-Antimalaryal Ajanlar | |
| 39 | İç Hastalıkları- Lökosit sayılarına yaklaşım ve değişiklikler 1-2 | |
| 40 | İç Hastalıkları-Anemili Hastaya Yaklaşım 1-2 | |
| 41 | İç Hastalıkları-Lenfadenomegali ve splenomegalili hastaya yaklaşım 1-2 | |
| 42 | İç Hastalıkları-Radyasyon Onkolojisi-Radyoterapinin Kanserdeki Yeri 1-2 | |
| 43 | İç Hastalıkları-Kanama ve Pıhtılaşma Bozukluklarına Yaklaşım 1-2 | |
| 44 | İç Hastalıkları-Hematopoietik sistem muayenesi ve hematopoez | |
| 45 | Mikrobiyoloji -Virüslere Giriş 1-2 | |
| 46 | Mikrobiyoloji-DNA Virüsleri Bulaşıcı İnsan 1-2-3-4 | |
| 47 | Mikrobiyoloji-Hepatit Virüsleri 7-8 | |
| 48 | Mikrobiyoloji - insanları enfekte eden RNA Virüsleri 1-2 | |
| 49 | Public Health -Cancer Epidemiology | none |
| 50 | Public Health -Quality of Life- | none |
| 51 | Public Health -Genetic Epidemiology | none |
| 52 | Public Health -Vector-borne Diseases | none |
| 53 | Scientific Research-Epidemiology and Its Applications | none |
| 54 | Radiology-1-Contrast agents and, Radiation security 1-2 | none |
| 55 | Radiology-Radiological Imaging methods1-2 | none |
| 56 | Radiology-Nuclear Medicine-Radiation, Biological Effects and Radiation Accidents 1-2 | none |
| 57 | Radiology-Nuclear Medicine-PET / CT in Oncology 1-2 | none |
| 58 | Radiology-Nuclear Medicine-Radiation Units, Measurement | none |
| 59 | Radiology- Overview of diagnosis and treatment in nuclear medicine | none |
| Resources |
| Lecture notes, Robbins/Kumar Pathologic basis of disease, macroscopic specimens, Jawetz Melnick & Adelbergs Medical Microbiology, 27th Edition, Nelson Textbook of Pediatrics, 2-Volume Set 21st Edition, Harrison's Principles of Internal Medicine, 20e |
| power point presentation, macroscopic plays, video presentation, brainstorming, case studies, question/answer |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ1: Knows the morphological and functional normal and abnormal structure of human body. | X | |||||
| 2 | PQ2: Knows the essential ways of determining the underlying causes of the pathologies with basic scientific approaches and the diagnoses of illnesses and disorders. | X | |||||
| 3 | PQ3: Knows the reasons for illnesses, the ways of protection, and the methods of promotion and improvement of public health. | ||||||
| 4 | PQ4: Knows the methods of advancing his/her knowledge about health and its practice. | ||||||
| 5 | PQ5: Accesses, interprets and applies the advanced interdisciplinary information related to health. | X | |||||
| 6 | PQ6: Performs a complete clinical examination of the human body, both morphologically and functionally and defines the problems. | X | |||||
| 7 | PQ7: Interprets examination data for diagnoses, compares with clinical data, and provides solutions. | X | |||||
| 8 | PQ8: Selects and applies appropriate tools for promotion and improvement of individual and public health. | X | |||||
| 9 | PQ9: Plans and conducts an advanced study of health independently. | ||||||
| 10 | PQ10: Takes responsibility individually and as a team member to solve the problems encountered in the promotion and improvement of individual and public health. | X | |||||
| 11 | PQ11: Takes responsibility for any intervention on the human body for the diagnosis and treatment. | X | |||||
| 12 | PQ12: Determines personal learning requirements and decides and develops a positive lifelong learning attitude. | X | |||||
| 13 | PQ13: Evaluates the information gained in the field of health with a critical approach. | X | |||||
| 14 | PQ14: Informs the patient, the relevant people and institutions, and the public about the health problem and conveys recommendations of solutions in writing and/or verbally. | X | |||||
| 15 | PQ15: Shares their recommendations on promotion and improvement of health with interdisciplinary experts by supporting with data. | X | |||||
| 16 | PQ16: Uses English at least at the General Level of European Language Portfolio B1, follows resources in his/her field and communicates. | X | |||||
| 17 | PQ17: Uses computer software, information, and communication technologies at least at the Advanced Level of European Computer Operating License. | X | |||||
| 18 | PQ18: Acts in accordance with social, scientific, cultural and ethical values in the stages of obtaining, interpreting, applying and announcing the data related to the field of health. | X | |||||
| 19 | PQ19: Develops strategy, policy and implementation plans on health issues and evaluate the results obtained the framework of quality processes. | ||||||
| 20 | PQ20: Systematically shares his/her works on promoting and improving health with quantitative and qualitative data and interdisciplinary experts. | ||||||
| 21 | PQ21: Has sufficient awareness on occupational health and safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 60 | |
| Rate of Final Exam to Success | 40 | |
| Total | 100 | |